Doctor’s Seminar : Pathophysiology, Diagnosis, and Latest Advancements in the Management of Keratoconus: Collagen Cross-Linking and Intacs, featuring Dr. Mujtaba A. Qazi, Director, Clinical Studies, Pepose Vision Institute
We are pleased to announce our clinical research study designed to evaluate the safety and efficacy of iontophoresis treatment with dexamethasone phosphate ophthalmic solution in patients who have non-infectious anterior segment uveitis. Iontophoresis is an investigational drug delivery system which...
New Clinical study: Announcing a new important clinical trial for wet AMD. This trial will investigate the safety and efficacy of a new, Ranibizumab sustained delivery platform for patients with wet AMD. This is a Genentech Phase II trial...
Vision Mission to Haiti: June 8-13, 2016 We are pleased to announce that Lifelong Vision Foundation sent Dr. Nancy Holekamp on our 2016 Vision Mission to La Gonave, Haiti. Dr. Holekamp provided vision screening and refraction tests to more than 400 kids...
New Doctor’s Seminar June : Dry Eyes and Allergies: Unique testing and treatments, featuring Dr. Jay Pepose, Medical Director, and Dr. Mujtaba A. Qazi, Director, Clinical Studies, Pepose Vision Institute
We’re partnering with 910 St. Louis non-profits for 24 hours of online giving. Visit Lifelong Vision Foundation’s Giving Page on May 3rd to make your donation to Lifelong Vision Foundation. Help us continue to help people see more clearly....
We are pleased to announce a new study for glaucoma, more specifically, mild or moderate primary open-angle glaucoma. This study is for people that are between the ages of 18 and 85 and need cataract surgery. In this study we’ll use a biodegradable,...
We pleased to announce a new clinical research study that will evaluate the effects and safety of Lampalizumab injection compared to sham procedure in patients with Geographic Atrophy, an advanced form of dry, Age Related Macular Degeneration? There are currently no...
We have completed our latest newsletter and will be sending it to everyone on our mail list. If you aren’t on our list but would like a copy, please give us a call.
